What's News
Article Outline
- Sentrx Animal Care Invited to Present Research at the Society for Biomaterials 2007 Annual Meeting
- White Paper Highlights a Bright Future for Equine Research
- Noted Biomedical Scientist Michael Kotlikoff is Named Dean of Cornell's College of Veterinary Medicine
- 10th Congress of the World Equine Veterinary Association
- Call for Abstracts—Deadline for Submission: July 15, 2007
Sentrx Animal Care Invited to Present Research at the Society for Biomaterials 2007 Annual Meeting
SentrX Animal Care, Inc., a leading provider of innovative healing biomaterials for horses and small animals, today announced that it will present new, forward-thinking research titled “Enhanced Wound Healing in Horses and Dogs Using Crosslinked Hyaluronic Acid-Based Films” at the Society for Biomaterials 2007 Annual Meeting held in Chicago, April 18−21.
SentrX Animal Care's Chief Operating Officer, Dr. Brenda Mann, will make the presentation. This will be Mann's eighth time presenting at the Society for Biomaterials.
Mann was invited to present SentrX Animal Care's research at the conference after a stringent peer review process. Mann's presentation will focus on how modified hyaluronic acid−based films accelerated reepithelialization of full-thickness wounds on the legs of both horses and dogs. The presentation will also highlight recommendations for future research, specifically focusing on how to create more effective treatment regimens and new product formulation. Mann's poster presentation will be available for viewing beginning April 19th in the main exhibit hall of the conference as well as at www.sentrxanimalcare.com.
Dr. Mann, a bioengineer and patent agent, has extensive experience in tissue engineering and wound healing. She received the Rice University Outstanding Woman Award in 1996, and the Young Investigator Award from the International Society for Applied Cardiovascular Biology in 2000. Dr. Mann was a founding faculty member of the Keck Graduate Institute of Applied Life Sciences and now serves on its Advisory Council. She is a Research Assistant Professor in the Department of Bioengineering at the University of Utah, and holds an adjunct faculty position at the University of Texas at El Paso.
The Society for Biomaterials is a professional society that promotes advances in all phases of materials research and development by encouragement of cooperative educational programs, clinical applications, and professional standards in the biomaterials field. The 2007 Annual Meeting of the Society for Biomaterials will cover three main sections: Nano to Macro Scale, Laboratory to Clinical Application, and Past to Future.
“We are pleased to present our research at the Society for Biomaterials annual conference,” said Dr. Richard Koehn, President and CEO of SentrX Animal Care. “The data being presented are encouraging as they further underscore the efficacy of SentrX's methods and products. The information will also support future independent studies conducted throughout the country as scientists strive to increase their scientific knowledge on how to effectively treat equine and small animal wounds.”
For more information on SentrX Animal Care, visit www.sentrxanimalcare.com
White Paper Highlights a Bright Future for Equine Research
In the past 2 decades, huge advances have been made in our understanding of many equine diseases. But we have a lot more to learn before we can truly improve the way many of these diseases are prevented or treated. One simply needs to consider the impact that laminitis had on Barbaro, a horse who captured everyone's imagination, or the effect that equine herpesvirus-I infections have had up and down the East Coast in the past few months. Although these diseases might be the most glaringly obvious at this time, they are not necessarily the most devastating to horses or the equine industry. Colic, osteoarthritis, neonatal septicemia, infertility, respiratory disease, laryngeal hemiplegia … the list of diseases needing attention goes on and on.
How are we going to address these diseases that threaten the health of our horses and the viability of the equine industry? How are we going to deal with new diseases and conditions as they arise? What are we going to do when diseases we thought were conquered suddenly reappear? More importantly, who is going to find the answers and solve these riddles?
Members of the Equine Research Coordination Group (ERCG) are making equine research funding a priority for future equine research. To advance this effort, the ERCG has developed an informative paper on the challenges of solving the equine research puzzle and the need for increased research funding.
The paper, “Ensuring a Bright Future for Equine Research,” can be viewed at http://www.aaep.org/equine_research_co_group.htm and is available for reprint. To learn more about equine research funding opportunities or current research, contact Anne Dadds, AAEP research coordinator, at adadds@aaep.org or (859) 233-0147, ext. 221, or Keith Kleine, AAEP director of industry relations, at (859) 233-0147, ext. 220, or kkleine@aaep.org.
The mission of the Equine Research Coordination Group (ERCG) is to advance the health and welfare of horses by promoting the discovery and sharing of new knowledge, enhancing awareness of the need for targeted research, educating the public, expanding fundraising opportunities, and facilitating cooperation among funding agencies.
The ERCG is a group comprising researchers and organizations that support equine research. Participants in the ERCG include equine foundations and multiple university research representatives. Current participants include: AAEP Foundation, American Horse Council, AQHA Foundation, Grayson-Jockey Club Research Foundation, Maxwell H. Gluck Equine Research Center, Morris Animal Foundation, Havemeyer Foundation, United States Equestrian Federation Foundation and University Researchers including: Noah Cohen, VMD (Texas A & M University), Greg Ferraro, DVM (University of California – Davis), Eleanor Green, DVM (University of Florida), Dick Mansmann, VMD (North Carolina State University), Wayne McIlwraith, BVSc (Colorado State University), Jim Moore, DVM (University of Georgia), and Rustin Moore, DVM (The Ohio State University). For more information about the ERCG, please visit online at http://www.aaepfoundation.org and click on the ERCG link.
Noted Biomedical Scientist Michael Kotlikoff is Named Dean of Cornell's College of Veterinary Medicine
by: Press Release
Michael I. Kotlikoff, professor and chair of the Department of Biomedical Sciences at Cornell University, has been named dean of the university's renowned College of Veterinary Medicine, Cornell President David J. Skorton and Provost Carolyn (Biddy) Martin announced today.
Cornell began a search for a new dean in April 2006, shortly after Donald F. Smith, the Austin O. Hooey Dean of Veterinary Medicine, announced he was stepping down on June 30, 2007, ending a 10-year deanship to return to the veterinary faculty. Kotlikoff's 5-year term as dean begins July 1.
“I am very pleased that Dr. Michael Kotlikoff will be the next dean of Cornell's College of Veterinary Medicine,” said Skorton. “Dr. Kotlikoff brings to his new post a distinguished record of scientific achievement and administrative leadership along with a good understanding of Cornell. His leadership will enhance the college's contributions in a complex and rapidly changing world.”
Provost Martin, who led the search effort with Search Committee chair Stephen Kresovich, vice provost for life sciences, said, “I am pleased that Professor Kotlikoff has agreed to lead the college. Mike has been an excellent chair of Biomedical Sciences, and I know he will bring that same dedication and vision to the deanship. He is an excellent scholar, who will work hard to protect and enhance our reputation as the premier institution for veterinary medical education and continue to build bridges between the life sciences in Ithaca and the Weill Cornell Medical College in New York City.”
The Cornell College of Veterinary Medicine was ranked the best veterinary college in the nation in U.S. News and World Report's 2008 edition of “America's Best Graduate Schools,” and it has consistently been ranked at the top since 2000.
“I am deeply honored to be chosen as the dean of Cornell's College of Veterinary Medicine and would like to thank Provost Martin, President Skorton, Vice Provost Kresovich and the Search Committee for their efforts on behalf of the college and their confidence in my abilities,” said Kotlikoff. “I look forward to working with faculty, students, staff, and friends to continue the outstanding tradition of innovation and leadership that has distinguished the college, and to maintain Cornell's position at the forefront of veterinary medicine.”
As dean, Kotlikoff will be the chief academic and administrative officer of the College of Veterinary Medicine, which has approximately 265 faculty, 680 staff members, 320 doctor of veterinary medicine (DVM), and 145 graduate students.
With an estimated annual budget of $100 million and more than 5,000 alumni, Kotlikoff will be responsible for overseeing the college's administrative operations and programs of teaching, research, and outreach, including the New York State Animal Health Diagnostic Laboratory, and will play a key leadership role in the college's relationship to the University and leaders of veterinary medicine in New York State and the nation.
Kotlikoff, who was recruited to Cornell from the University of Pennsylvania in 2000, has chaired the Provost's Cornell Local Advisory Committee and the Mammalian Genomics Initiative; served on the Cornell Genomics and Life Sciences Task Force, the Cornell Institute for Biotechnology and Life Science Technologies Scientific Administrative Board, and the Cornell Neurosciences Steering Committee; and directs the Cornell Core Transgenic Mouse Facility.
His laboratory is internationally recognized in the areas of mouse genetics, cardiac and smooth muscle biology, and cell signaling. Kotlikoff has pioneered efforts to understand complex physiologic processes at the molecular level through the use of genetics, molecular design, and advanced optics. Work from his laboratory has provided vital insights into heart development, injury, and repair, and the molecular basis for abnormal muscle contractility.
At the University of Pennsylvania, Kotlikoff was Professor and Chair of the Department of Animal Biology and Director of the Center for Animal Transgenesis and Germ Cell Research in the School of Veterinary Medicine, and held a joint appointment in the Department of Medicine in the School of Medicine. He received his VMD, summa cum laude, from Penn in 1981 and earned his PhD from the University of California−Davis in physiology.
10th Congress of the World Equine Veterinary Association
January 28 – February 1, 2008
Moscow, Russia
Sponsored by:
World Equine Veterinary Association (WEVA) &
Russian Equine Veterinary Association (REVA)
Under the support of:
Ministry of Agriculture of Russian Federation &
Russian Academy of Agricultural Sciences
Call for Abstracts—Deadline for Submission: July 15, 2007
For its bi-annual meeting held in Moscow in January, 2008, the WEVA Scientific Committee is looking for abstract proposals with various types of communications: state-of–the-art subjects, research topics, “How-to-do,” or infectious diseases and epidemiology topics, presented as either oral communications or posters.
Submission of abstracts should be done in electronic form or eventually sent on a disk (Word format) completed with a signed and dated paper form.
The author can indicate his or her preference for oral or poster presentation, but the final decision will be made by the Congress Scientific Committee. Authors will be informed of acceptance within 2 months after the deadline for submission. Instructions relative to oral or poster presentations will be provided then.
Please send abstracts to: congress@weva2008.ru
Information:
Dr. Ekaterina F. Zabegina
Russian Equine Veterinary Association, REVA
P.O. Box 53, Moscow, 109444, Russia
Inquiries by tel : +7 (495) 740 28 74
fax : +7 (495) 945 63 86
PII: S0737-0806(07)00197-9
doi:10.1016/j.jevs.2007.05.005
